Hand in hand: a Whole-School approach to preventing teen suicide

NCT ID NCT07722455

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial tests a suicide prevention program called 'Hand in Hand, We Rise' in six rural Chinese junior high schools. The program combines a strengths-based curriculum for students, gatekeeper training for teachers, and mental health information for caregivers. Researchers are evaluating whether this multi-stakeholder approach is feasible and acceptable, and whether it can reduce suicidal thoughts, depression, and anxiety among adolescents aged 11 to 15.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A multi-stakeholder school-based suicide prevention program combining a student strengths curriculum, teacher gatekeeper training, and caregiver mental health information
What this could lead to
If effective, this program could offer a scalable model for preventing teen suicide in underserved rural schools.
What could go wrong
This is an early feasibility trial with only six schools, so results may not generalize. The program requires coordination across multiple groups, which may be hard to sustain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MENTAL HEALTH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Psychological Well-Being Suicide Suicide Prevention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Six middle schools

    Linquan County, Anhui, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.